北京美科美生物公司代理lepumedical

Fight Against Covid-19
Medical Devices
Pharmaceutical (API)


浙江乐普药业有限公司（原浙江新丹空药业有限公司）成立于2001年，占地15.2万平方米，现位于浙江省台州市椒江化工原料药工业园。2014年，乐普医疗科技（北京）有限公司被引入管理层，并成为控股股东。2018年，“浙江乐浦”正式命名。
浙江乐普主要从事心血管、抗生素、肿瘤、神经系统等领域原料药和FDF的研发、生产和销售。主要产品包括阿托伐他汀钙、诺氟沙星、瑞舒伐他汀钙等，建立了完善的GMP体系，拥有中国CFDA认证、美国FDA认证、英国MHRA认证、欧盟COS认证、日本PMDA认证、韩国KFDA认证等，多个产品类别均处于全球领先地位。
公司拥有院士工作站和联合实验室，与清华大学、南开大学、浙江工业大学、中国医药工业研究所等著名高校和科研机构联合，现已认定为高新技术企业。我们与20多家国际制药公司广泛合作，加快心血管、肿瘤等新药的研发，为公司中长期发展提供可持续动力。
Zhejiang Lepu Pharmaceutical Co.,Ltd. (formerly known as Zhejiang Neo-Dankong Pharmaceutical Co.,Ltd.), founded in 2001, with an area of 152,000 square meters, is now located in Jiaojiang Chemical API Industrial Park, Taizhou City, Zhejiang Province. In 2014, Lepu Medical Technology (Beijing) Co., Ltd. was introduced into the management then becoming the controlling shareholder. In 2018, the name of "Zhejiang Lepu" was officially announced.
Zhejiang Lepu is mainly engaged into R&D, production and sales of APIs and FDFs for Cardiovascular, Antibiotics, Oncology, Nervous System and other categories. Main products include Atorvastatin Calcium, Norfloxacin, Rosuvastatin Calcium, etc. A solid GMP system has been well established, with certifications including CFDA for China, FDA for USA, MHRA for UK, COS for EU, PMDA for Japan, KFDA for South Korea, etc. Many product categories are taking the global-leading positions.
The company has state-level academician workstation and joint laboratories with renowned universities and research institutes, including Tsinghua University, Nankai University, Zhejiang University of Technology, China State Institute of Pharmaceutical Industry, now recognized as a state-level high-tech enterprise. We have extensive cooperation with more than 20 international pharmaceutical companies, speeding up the R&D of cardiovascular, oncology and other new drugs which provides sustainable power for medium and long-term development for the company.